Low risk — use of or exposure to this product is not likely to cause adverse health consequences.
PSYLLIUM FIBER Recalled by Konsyl Pharmaceuticals Inc Due to Labeling: Label Error on Declared Strength; Listed active...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Konsyl Pharmaceuticals Inc directly.
Affected Products
PSYLLIUM FIBER, Laxative/Supplement, 100 Capsules, OTC. Manufactured By: Konsyl Pharmaceuticals, Inc., Easton, MD 21601. NDC: 0224-1847-10.
Quantity: 6286 Bottles
Why Was This Recalled?
Labeling: Label Error on Declared Strength; Listed active ingredient strength is inaccurate.
Where Was This Sold?
This product was distributed to 8 states: FL, MN, NY, OH, OR, PA, SC, TX
About Konsyl Pharmaceuticals Inc
Konsyl Pharmaceuticals Inc has 1 total recall tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report